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Abstract
Objective: Different types of carbohydrates have diverse glycemic response, thus glycemic index (GI) and glycemic load (GL)
are used to assess this variation. The impact of dietary GI and GL in all-cause mortality is unknown. The objective of this
study was to estimate the association between dietary GI and GL and risk of all-cause mortality in the PREDIMED study.
Material and Methods: The PREDIMED study is a randomized nutritional intervention trial for primary cardiovascular
prevention based on community-dwelling men and women at high risk of cardiovascular disease. Dietary information was
collected at baseline and yearly using a validated 137-item food frequency questionnaire (FFQ). We assigned GI values of each
item by a 5-step methodology, using the International Tables of GI and GL Values. Deaths were ascertained through contact
with families and general practitioners, review of medical records and consultation of the National Death Index. Cox regression
models were used to estimate multivariable-adjusted hazard ratios (HR) and their 95% CI for mortality, according to quartiles of
energy-adjusted dietary GI/GL. To assess repeated measures of exposure, we updated GI and GL intakes from the yearly FFQs
and used Cox models with time-dependent exposures.
Results: We followed 3,583 non-diabetic subjects (4.7 years of follow-up, 123 deaths). As compared to participants in the lowest
quartile of baseline dietary GI, those in the highest quartile showed an increased risk of all-cause mortality [HR=2.15 (95% CI:
1.15–4.04); P for trend =0.012]. In the repeated-measures analyses using as exposure the yearly updated information on GI, we
observed a similar association. Dietary GL was associated with all-causemortality only when subjects were younger than 75 years.
Conclusions: High dietary GI was positively associated with all-causemortality in elderly population at high cardiovascular risk.
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Introduction
The epidemiological transition and increased prevalence of
chronic-degenerative diseases in the elderly population is related to
nutritional status. In Spain, 35% of the population aged 65 years
or more is obese [1]. Obesity, especially visceral obesity, confers an
increased risk of mortality not only from cardiovascular diseases
(CVD) but also from other causes such as cancer or diabetes and
its complications [2].
Currently, dietary recommendations from FAO and WHO to
prevent chronic diseases are aimed to reduce or change the
proportion of fats to a healthier profile, while increasing the
carbohydrate content of the diet [2–5]. Although these recommen-
dations establish a limit in the intake of free sugars and suggest the
ideal amount of fiber consumption, they are not specific in relation
to the quality of the dietary carbohydrates [2–5]. New evidence-
based recommendations from the WHO are being prepared and
probably further adjustments will be made regarding the proportion
of fat and sugar intake. However, both the quality and the amount
of carbohydrates, generate different responses of insulin secretion
and postprandial glucose [6]. Thus, Jenkins et al. [7] introduced the
concept of glycemic index (GI). GI is defined as the postprandial
blood glucose response of a test food, compared to the response of
the same amount of available carbohydrate in a reference food
consumed by the same subject. Similarly, glycemic load (GL)
evaluates the overall glycemic effect of the diet, multiplying the
glycemic index of the diet by the content of total carbohydrates
consumed by the individual [8]. Dietary GI and GL were developed
to measure the average daily consumption of an individual in terms
of quality and amount of available carbohydrates [9].
Current research has evaluated the relationship between dietary
GI and GL in the prevention and study of obesity, CVD, cancer
and many other health problems, such as macular degeneration
[6,9–12].
The literature to confirm the relationship between GI and GL
for overall fatal events is scarce. In fact, usually, references are
related to specific causes of fatal events such as cancer [13] and
cardiovascular disease mortality [14,15]. The association between
dietary GI and GL and the risk of total mortality has been
investigated in men with established CVD [16] and breast cancer
survivors [17], but no significant associations were found between
all-cause mortality when comparing the highest intakes of dietary
GI and GL vs. the lowest. Furthermore, an association between
higher intake of dietary GL and risk for all-cause mortality has
been found in diabetic subjects with normal weight [18]. Similarly,
Baer et al. [19] found a relationship in women aged 30–55 years:
an increase of 41 units of GL, augment by 22% the risk for total
mortality.
The association between GI/GL and all-cause mortality is still
unclear; therefore, we aimed to evaluate the association of the
quality of carbohydrates on all-cause mortality in an elderly
population at high cardiovascular risk.
Materials and Methods
Study design
This study was conducted within the frame of the PREDIMED
study (PREvencio´n con DIeta MEDiterra´nea), a randomized,
multicenter, parallel group, single-blinded dietary intervention
trial conducted in Spain (Trial Registration: clinicaltrials.gov
Identifier: ISRCTN35739639) [20]. The main objective of the
trial was to analyze the effect of the Mediterranean Diet (MeDiet)
on major cardiovascular disease prevention when comparing to a
control diet [20]. Participants were randomly assigned to three
groups: MeDiet supplemented with extra virgin olive oil (MeDiet +
EVOO), MeDiet with nuts (MeDiet + nuts), and the control
group. Participants received dietary training without calorie
restriction or advice on physical activity [20]. After the completion
of the trial, the PREDIMED study provided an opportunity for
conducting the long-term follow-up of a large observational cohort
of high cardiovascular risk subjects in a Mediterranean setting
[21]. The design of the PREDIMED study has been reported in
detail elsewhere [21]. The protocol was approved by the
institutional review boards of each recruitment center and all
participants provided a written informed consent prior to their
inclusion in the study.
Study population
The PREDIMED study included 7447 participants, aged
between 55 and 80 years. Subjects without prior CVD were
selected when they met at least one of the following criteria:
presence of type 2 Diabetes Mellitus (T2DM) or the presence of
three or more cardiovascular risk factors (current smoking,
hypertension, high LDL cholesterol ($160 mg/dl), low HDL
cholesterol (#40 mg/dL in men and #50 mg/dL in women),
overweight or obesity (BMI$25 kg/m2), or family history of
premature CVD).
For this analysis, we selected participants without T2DM at
baseline (n = 3833). Exclusion criteria were: subjects without
follow-up (n = 125), with values of total energy intake outside of
predefined limits (,800 or.4000 kcal/d in men and: ,500 or.
3500 kcal/d in women) (n = 86), use of anti-diabetic medication
(n = 21) and incomplete data in any variable used in the analyses
(n = 18). Overall, 3,583 subjects were analyzed in this study. The
rationale for exclusion of persons with a baseline history of
diabetes mellitus (including type 1 diabetes, T2DM or use of anti-
diabetic medication) was potential effect modification and
potential changes in the diet as a result of diagnosis and treatment
of T2DM.
Dietary assessment
Trained dietitians used a 137–item food frequency question-
naire (FFQ) to assess dietary habits by face-to-face interviews. This
FFQ was repeatedly administered each year during follow-up. The
FFQ has been validated in a sample of subjects with similar
characteristics to the participants of the PREDIMED study [22].
Energy (kcal/day) and nutrient intake (g/day) were calculated as
frequency multiplied by nutrient composition of specified portion
size where frequencies were measured in nine categories for each
food item. Nutrient data bank was updated using the latest
available information included in food composition tables for
Spain [23]. Alcohol intake was also ascertained through the use of
this questionnaire. Carbohydrates, proteins, fat and dietary fiber
intakes, GI and GL were adjusted for total energy intake using the
residual method proposed by Willet [24].
Glycemic Index and Total Mortality Risk in a Mediterranean Population
PLOS ONE | www.plosone.org 2 September 2014 | Volume 9 | Issue 9 | e107968
Estimation of dietary GI and GL
We assigned the GI of each food of the FFQ using Louie et al.
protocol [25] with the International Tables of GI and GL values
[26] and the Sydney University GI research service [27]. Values
were extracted from published studies conducted in normal
subjects, using glucose as reference food [26].
After the GI assignment, we estimated dietary GI for each
individual summing the GI of each food multiplied by the amount
of available carbohydrate consumed (g/day) and divided by the
total available carbohydrate amount. For dietary GL, the sum of
the GI multiplied by the amount of available carbohydrate
consumed was divided by 100 [28]. Energy-adjusted dietary GI
and GL intake was finally categorized into quartiles. To assess the
repeated measurements of diet, we updated GI and GL values
from the yearly FFQs.
Other measurements
Socio-demographic information, medical history and lifestyle
habits were collected via specific questionnaires carried out by
trained personnel. Height and weight were measured wearing light
clothes, barefoot, using a wall-mounted stadiometer and calibrated
scales. BMI was estimated as weight (kg) divided by the height (m2)
squared. We estimated energy expenditure using a validated
Spanish version of the Minnesota leisure-time physical activity
questionnaire [29,30].
Outcome ascertainment
All-cause mortality was determined by review of the End Point
adjudication Committee. This panel was blinded to the interven-
tion group. Information on all-cause mortality was updated on a
yearly basis. Information on the occurrence of each fatality was
initially obtained from the continuous contact with participants
and their families that we had during the trial, contact with family
physicians, the yearly comprehensive review of all medical records
and by yearly consultation of the National Death Index. The
analyses included cases confirmed between October 1st, 2003, and
December 1st, 2010.
Statistical analysis
Baseline characteristics of the population and dietary intakes
were calculated according to quartiles of dietary GI and GL.
Follow up time was calculated from the date of recruitment to the
date of either death or end of follow-up (the date of the last visit or
the last recorded clinical event of participants still alive). Different
Cox regression models were used to estimate multivariable-
adjusted hazard ratios (HR) and their 95% CI for all-cause
mortality according to baseline quartiles of energy adjusted dietary
GI and GL. A first model was adjusted for sex, age (years),
recruitment center and intervention group (Med Diet + EVOO,
Med Diet + Nuts and control diet). A second model was further
adjusted for potential confounders including: smoking (never, past,
current), education (low, middle, high, no data available), marital
status (married, other), physical activity (continuous), BMI
(continuous), self-reported history of cancer (yes, no), self-reported
history of arterial hypertension (yes, no), self-reported history of
dyslipidemia (yes, no), self-reported history of cardiovascular
disease (yes, no), total energy intake (continuous), alcohol intake
(continuous) and dietary fiber intake (continuous, energy adjusted).
The third model was further adjusted for saturated fatty acids
(continuous, energy adjusted) and monounsaturated fatty acids
(continuous, energy adjusted). In all the analyses, recruitment
center was entered into the model through the strata statement.
Tests of linear trend across increasing quartiles of GI and GL were
conducted by assigning the medians to each quartile and these
variables were treated as continuous in the multivariate models.
To assess a possible interaction between dietary GI/GL and sex or
intervention group, we introduced product terms in the different
multivariable models and considered p,0.05 in the likelihood
ratio test as statistically significant.
To update GI and GL intake with all available longitudinal
data, we used Cox regression models with time-dependent
exposures. Three models were adjusted using the same covariates
used for the models of baseline analysis. For dietary measures, we
used the cumulative average of food intakes from baseline to the
censoring events. BMI and physical activity were also yearly
updated. Because changes in diet after development of diabetes
may confound the association between exposure and mortality
[31], we stopped updating dietary variables at the time interval
during which individuals developed T2DM.
Finally, sensitivity analyses were conducted using quartiles of
energy-adjusted GI and GL specific for different groups of the
population to observe the effect of changing energy limits
(percentiles 1 and 99, percentiles 5 and 95), including population
with T2DM, excluding obese subjects (BMI$30 kg/m2) and
including only obese subjects, excluding participants with more
than 6 years of follow-up and exclusion of subjects aged 75 years
or more. Statistical analyses were performed using Stata 12.0
(StataCorp, College Station, TX, USA) and the significance level
was set at p,0.05.
Results
In this study, participants were followed for a median of 4.7
years. Of 3,583 subjects, 123 cases of all-cause mortality were
registered. The mean (SD) dietary GI and GL of participants at
recruitment was 57.6 (4.7) and 117.6 (24.1) respectively. Table 1
shows the main baseline characteristics of the population
according to energy adjusted dietary GI and GL quartiles.
Subjects in the top quartile of dietary GI differed from the
individuals in the lowest quartile in that they were younger and
more often male, were more likely to be current smokers and more
likely to be married. Participants in the highest quartile of dietary
GI also had slightly lower BMI (20.6 kg/m2), higher consumption
of alcohol and carbohydrate but less intake of protein, fat and
dietary fiber than the subjects in the bottom quartile of dietary GI.
Characteristics according to dietary GL were similar to GI
excepting that subjects in the highest quartile of GL were more
often female, older, less likely to be current smokers, more likely to
have only primary education, less likely to be married and
physically active, had lower alcohol consumption, lower energy
intake had higher intake of fiber when compared to the lowest
quartile. The proportion of prevalent diseases such as cancer or
arterial hypertension was similar across quartiles of dietary GI and
GL. According to intervention group, mean dietary GI and GL
were significantly higher when comparing the highest quartiles vs.
the lowest.
We found a significant association between the highest quartile of
dietary GI and all-cause mortality (Table 2). In the first model,
subjects in the top quartile of baseline dietary GI had a 2.2 fold risk
of all-cause mortality vs. subjects in the lowest quartile [HR = 2.22
(95% CI: 1.26–3.94); p for trend = 0.002]. After multivariate
adjustment, this association was attenuated but remained significant
[HR = 2.15 (95% CI: 1.15–4.04); P for trend = 0.012]. Our results
revealed a higher risk for all cause mortality and baseline dietary GL
in the multivariate analysis although it did not reach statistical
significance [HR = 1.95 (95% CI: 0.97–3.90); p for trend = 0.072].
No significant interactions with sex or intervention group were
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observed. In the repeated measurement analyses using as exposure
the yearly updated information on GI, we found a significant
association with all-cause mortality [HR = 2.25 (95% CI: 1.16–4.36)
for the highest versus the lowest quartile; p for trend = 0.014].
Regarding updated dietary GL, we observed that subjects in the top
quartile had around 75% higher risk for mortality when compared
to those in the bottom quartile, however, this association did not
achieve statistical significance.
Results from sensitivity analyses comparing the risk of mortality
between the upper quartiles (quartile 3 and quartile 4) of GI and
GL with reference to the lowest quartile are shown in Table 3.
We also found positive associations between the upper quartile of
dietary GI with all-cause mortality when considering energy limits
as percentiles 1 and 99 or percentiles 5 and 95, and in subjects
younger than 75 years. Finally, obese subjects in the top quartiles
of dietary GI presented a 3-fold increased risk for all-cause
mortality with a statistically significant positive trend (p for trend
= 0.044). Dietary GL was associated with all-cause mortality when
we excluded participants with total energy intake lower than
percentile 1 or higher than percentile 99 [HR = 2.10 (95% CI:
1.03–4.27) for the highest versus the lowest quartile; p for trend
= 0.042] and when we restricted the analysis to subjects younger
than 75 years [HR = 3.16 (95% CI: 1.32–7.54); p for trend
= 0.019].
Discussion
We found that higher intake of baseline dietary GI was
associated with an increased risk of all-cause mortality in 3,583
non-diabetic elderly subjects. This association remained significant
in the repeated measurement analysis. With respect of dietary GL,
we observed a higher risk of all-cause mortality only in subjects at
high risk of CVD younger than 75 years.
Our results differ from a cohort of Swedish men, aged from 45
to 79 years with prior cardiovascular disease, where no association
was found between dietary GI nor GL and all-cause mortality
[16]. We did not find a relationship for all-cause mortality and
dietary GL for the original sample evaluated; however, the
association was statistically significant for subjects younger than 75
years. This effect is similar to the Nurses’ Health Study, where GL
was identified as a risk factor for all-cause mortality among 50,112
women aged 30–55 years [19]. It is of interest to note that in the
Nurses’ Health study a significant association was found with
‘‘other causes’’ but not with CHD and cancer mortality.
Therefore, the differences could be explained because our study
was conducted in aged population at high cardiovascular risk and
our endpoint incorporated all causes of death, including CHD and
cancer.
Our results also agree with a previous study where Oba et al.
reported an association of similar magnitude between dietary GI
and mortality from stroke risk in women. No associations were
observed between dietary GL and the risk of total stroke or death
from ischemic stroke [15]. A positive trend was found for GL and
death from hemorrhagic stroke in women. In our study, a
significant trend was found in the sensitivity analysis only in
subjects younger than 75 years. When individuals over 75 years
were analyzed, no associations were found between dietary GI nor
GL with all cause mortality (data not shown). This fact reflects that
the oldest subjects in our sample could be attenuating our results
due to age-related influences, such as deterioration in glucose
metabolism. Pancreatic, insulin receptor, and post-receptor
changes associated with aging are critical components of the
endocrinology of aging. Apart from decreased (relative) insulin
secretion by the b cells, peripheral insulin resistance related to
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poor diet, physical inactivity, increased abdominal fat mass, and
decreased lean body mass contribute to the deterioration of
glucose metabolism [32]. Furthermore, this age-effect is similar to
previous findings, where the association between obesity and
mortality was attenuated with advancing age [33]. However the
age-related weaker associations may reflect confounding from
cohort variation in mortality risk, healthy participant effects (i.e.,
biases introduced by survey selection of healthy respondents) or
duration of exposition to the risk factor [34]. Therefore, we
consider that it can be not concluded whether dietary GL is
associated with higher risk of mortality in older subjects and
further studies with a larger sample size and follow-up are needed
to confirm the association between dietary GL and all-cause
mortality. Our results alternatively, may indicate that, in this
population at high cardiovascular risk, the quality of carbohy-
drates (represented by dietary GI) could be more important than
its quantity (partially represented by dietary GL) in predicting all-
cause mortality [15].
We identified an association between the highest quartiles of
dietary GI and risk of all-cause mortality in obese subjects. Two
recent meta-analyses have shown that the effect of dietary GL on
the risk of coronary heart disease appeared more evident in
subjects with higher BMI, although the authors recommended
treating this information with caution because of the limited
evidence and diversity among the BMI cut-off points used across
studies [35,36]. Nevertheless, the individual response to a given
carbohydrate load is influenced by the degree of insulin resistance,
which is, firstly determined by the degree of adiposity, and also by
physical activity, genetics, and other aspects of diet. Thus, it might
be expected that the adverse metabolic effects of high-GI foods
would be exacerbated in sedentary, overweight, or genetically
susceptible persons [37].
Furthermore, higher values of dietary GI or GL could increase the
risk of all-cause mortality by raising the risk of chronic diseases.
Recent meta-analyses have shown a relationship between dietary GI,
GL and increased risk of CVD in women but not in men [35,38,39],
greater risk of T2DM [6,40,41], and risk for certain types of cancer
such as colorectal or endometrial ones [11,42]. Higher dietary GI
has also been associated with an increased risk of breast cancer
[6,11,43] although these results are contradictory [44–46].
After a high-GI meal, blood glucose concentration increases at
least twice that after a low-Gl meal with the same nutrients and
energy. This hyperglycemia stimulates insulin release and inhibits
glucagon liberation. High insulin-to-glucagon ratio affects normal
anabolic responses such as uptake of nutrients by insulin-
responsive tissues, glycogenesis, lipogenesis, and inhibits gluco-
neogenesis and lipolysis. From 2 to 4 hours after a high-GI meal,
the absorption from the gastrointestinal tract declines, but the
effects of hiperinsulinemia and low glucagon remain. Blood
glucose drops to lower hypoglycemic range and release of free
fatty acid is more suppressed than compared with a low-GI meal.
In the late postprandial period, the low circulating concentration
of metabolic fuel activates the hormone response that restores
euglicemia and elevates free fatty acids to higher levels than
observed after low-GI meals [47].
Eventually these postprandial responses may contribute to insulin
resistance and obesity [48]. In a meta-analysis, Livesey
et al. found that reduction in GL was associated with a decrease
in body weight and vice versa [49]. When comparing high GI foods,
such as white bread, Bautista-Castan˜o et al. found a dose-response
relationship between the increase in white bread consumption and
weight or waist circumference gain [50]. However, these results are
inconsistent. A systematic review of 14 randomized controlled trials
did not find differences in the effect of low GI/GL vs. high GI/GL
diets on anthropometric data, but decreases in C-reactive protein
and fasting insulin were significant in the low GI/GL groups [51].
Additionally, higher dietary GI has been associated with small
increases in C-reactive protein [52] which has been related to all-
cause mortality [53]. Another European study conducted in
overweight subjects, showed that following a low GI diet after a
weight loss intervention, had a greater decrease of high sensitivity
C-reactive protein blood levels than the high GI groups [54].
Moreover, in the PREDIMED study, top quartiles of dietary GI
were associated with higher plasma levels of TNF and IL-6 than
those in the lowest quartiles [55].
A study conducted in healthy elderly Europeans found that a
posteriori plant-based dietary pattern was associated with lower
all-cause mortality. This plant-based pattern with high intakes of
vegetables, vegetable oils, fruit, legumes and pasta/rice/other
grains and low intakes of potatoes, margarine and non-alcoholic
beverages, was correlated with the MeDiet pattern [56]. A
previous study has shown that greater adherence to the MeDiet is
inversely associated with dietary GI and GL [57]. A high degree of
adherence to the MeDiet has been associated with a reduction in
total mortality [58–62], obesity [63–65], T2DM [66,67], major
cardiovascular events [21,68] and their risk factors [23]. Thus,
Estruch et al. [23] assessed the effects of a 3-month intervention
with MeDiet on changes in cardiovascular risk factors within the
PREDIMED trial. MeDiet supplemented with EVOO, reduced
C-reactive protein levels. Moreover, other inflammation biomark-
ers such as interleukin-6, intercellular adhesion molecule-1
(ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)
decreased in subjects following a MeDiet supplemented either
with EVOO or nuts [23]. Even more, after one year of
intervention with MeDiet, the prevalence of metabolic syndrome
was reduced by 13.7% when compared with control group [69].
However the number of randomized controlled-feeding trials that
compare low vs. high GI/GL diets and that include measures of
glucose homeostasis, blood lipids or inflammation is limited [70].
The limitations of this study are mainly methodological. Firstly,
due to the scarcity of GI values for Spanish foods, we used as
reference GI data from other countries. This fact could be a source
of bias, because GI values may differ wide ranges, depending on
variety, processing and cooking [71]. Secondly, the FFQ was not
designed to evaluate dietary GI and dietary GL. Thirdly, we
conducted the study in elderly subjects at high cardiovascular risk.
Therefore, our results cannot be generalized to other populations.
Finally, our study was conducted in a cohort that went through a
nutritional intervention, which may have had an effect on dietary
GI and GL. However, in order to address this issue, we adjusted
all analyses by intervention group to minimize the effect.
Moreover, because updated dietary information during the
follow-up was used in our analyses, we accounted for changes in
dietary habits over time. To our knowledge, this is the first large
cohort study assessing GI and GL with yearly repeated measure-
ments of diet. Repeated measurements of diet capture changes in
dietary exposure, but also contribute to overcome, at least
partially, the potential problems of measurement errors in
nutritional epidemiology. Our study also has other strengths, such
as the large sample size that allowed us to adjust for all possible
potential confounders in the multivariate analyses. Other strengths
are the use of a comprehensive and validated FFQ and the
assignment of GI values trough an established protocol.
Conclusions
In summary, this study provides evidence that high GI diets are
related to increased risk of all-cause mortality in non-diabetic
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elderly subjects at high cardiovascular risk. In the sensitivity
analyses this association was statistically significant when subjects
were younger than 75 years or obese. Nevertheless, more evidence
is necessary to evaluate these associations in different population
groups and further studies that elucidate the mechanisms
supporting the inclusion of GI and GL in dietary recommenda-
tions.
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